Barrett's esophagus.
The columnar replacement of squamous epithelium in the lower esophagus is the result of gastroesophageal reflux. Whether the squamous cells are replaced or undergo metaplasia is still conjectural. This neoepithelium is unstable in the presence of continued reflux and prone to complications of stricture, ulceration, and adenocarcinoma. Considerable evidence supports the hypothesis that duodenal contents play a role in the development of Barrett's esophagus and its complications. The increasing incidence of adenocarcinoma in Barrett's esophagus is of concern in the Western World. Surveillance programs in some centers have been successful in early diagnosis, and excellent survival periods have been reported following resection in these cases. Both medical and surgical antireflux treatment is successful in symptom relief, but even in the absence of symptoms, reflux may continue. Surgery offers better overall results than proton pump inhibition of gastric acid and has been more popular since less aggressive (minimally invasive) techniques have been popularized. Mucosal ablation and antireflux measures by medicine or surgery are still in the experimental stages but hold considerable promise for the future.
Bremner
C G
CG
Department of Surgery, University of Southern California, Los Angeles, USA.
Bremner
R M
RM
D001471:Barrett Esophagus / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D016145:Endoscopy, Digestive System; D004947:Esophagus / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery; D018662:Fundoplication; D006801:Humans; D008365:Manometry; D011183:Postoperative Complications; D011859:Radiography; D016896:Treatment Outcome